Topical therapies for treatment of CIN 2-3

Ended Awarded Last action

Contract number
HHSN26100011
Awardee
Awarding agency
Obligated
$763,665

Award facts

Opportunity
  • N01CN0501469 Solicitation number
Contract value 74% obligated
  • $763,664.83 Current, with exercised options
  • $1,027,142.83 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Tucson, AZ 85719, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · DE-obligation of expiring FY 2020 funding in accordance with 31 U.S.C. 1552(a) -$19,335
Funding Only Action P00007 · DE-obligation of expiring FY 2018 funding in accordance with 31 U.S.C. 1552(a) -$19,050
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Exercise an Option P00004 · Topical therapies for treatment of CIN 2-3 cancer prevention agent development program: early phase clinical research $137,306
Change Order P00003 · Additional funds to supplement base (line 1) for additional intervention costs topical therapies for treatment of CIN 2-3 cancer prevention agent development… $87,990
Change Order P00002 $0
Change Order 1 $171,153
Original award $405,600

About this award

This is a delivery order under the Cancer Prevention Agent Development Program 2012-2017 IDIQ contract, awarded by the National Cancer Institute to the University of Arizona for a value of $1,027,142.83. The contract is for the development of topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) grades 2-3, with a period of performance through September 15, 2023. The contract does not have a set-aside designation. The University of Arizona has subcontracted a portion of the work to the University of California, Los Angeles to support early phase clinical research for the cancer prevention agent development program.

Quick answers

Who was awarded contract HHSN26100011?

HHSN26100011 was awarded to University Of Arizona by National Cancer Institute (National Institutes of Health) on September 15, 2017.

How much is contract HHSN26100011 worth?

The government has obligated $763,665 on HHSN26100011. Its potential value, with all options, is $1,027,143.

Is contract HHSN26100011 an order under another contract?

Yes. HHSN26100011 is a delivery order under HHSN261201200031I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100011 competed?

The extent of competition for HHSN26100011 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award